Arama Sonuçları Issues. - Daraltılmış: Drug development.SirsiDynix Enterprisehttps://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dIssues.$0026qf$003dSUBJECT$002509Konu$002509Drug$002bdevelopment.$002509Drug$002bdevelopment.$0026ic$003dtrue$0026ps$003d300?2026-01-21T20:32:23ZControversial statistical issues in clinical trialsent://SD_ILS/0/SD_ILS:5475542026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Chow, Shein-Chung, 1955, author.<br/>Yer Numarası RM301.27 .C475 2011<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439849620">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Inhaled pharmaceutical product development perspectives : challenges and opportunitiesent://SD_ILS/0/SD_ILS:4598792026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Hickey, Anthony J., 1955- author.<br/>Yer Numarası ONLINE<br/>Elektronik Erişim ScienceDirect <a href="http://www.sciencedirect.com/science/book/9780128122099">http://www.sciencedirect.com/science/book/9780128122099</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Handbook of Bioethical Decisions. Volume I Decisions at the Benchent://SD_ILS/0/SD_ILS:5278542026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Valdés, Erick. editor. Lecaros, Juan Alberto. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-29451-8">https://doi.org/10.1007/978-3-031-29451-8</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Solid state development and processing of pharmaceutical molecules : salts, cocrystals, and polymorphisment://SD_ILS/0/SD_ILS:5970462026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Gruss, Michael, author.<br/>Yer Numarası RS403 .G78 2022<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527823048">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527823048</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Characterization of pharmaceutical nano- and microsystemsent://SD_ILS/0/SD_ILS:5961672026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Peltonen, Leena Johanna, 1970- editor.<br/>Yer Numarası RS192<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119414018">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119414018</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Early drug development : bringing a preclinical candidate to the clinic. Volume 1-2ent://SD_ILS/0/SD_ILS:5945852026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Giordanetto, Fabrizio, editor.<br/>Yer Numarası RM301.27 .E27 2018<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527801756">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527801756</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Pharmaceutical nanotechnology : innovation and productionent://SD_ILS/0/SD_ILS:5931972026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Voorde, M. H. van de (Marcel H.), editor. Cornier, Jean, editor. Kwade, Arno, editor. Owen, Andrew, editor.<br/>Yer Numarası RM301.25<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527800681">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527800681</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Safety pharmacology in pharmaceutical development : approval and post marketing surveillanceent://SD_ILS/0/SD_ILS:5467782026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Gad, Shayne C., 1948, author. Gad, Shayne C., 1948- Safety pharmacology in pharmaceutical development and approval.<br/>Yer Numarası RM301.25 .G33 2012<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439845684">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Generic drug product development : specialty dosage formsent://SD_ILS/0/SD_ILS:5459532026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Shargel, Leon, 1941- Kanfer, Isadore.<br/>Yer Numarası RS55.2 .G456 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420020038">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Active pharmaceutical ingredients : development, manufacturing, and regulationent://SD_ILS/0/SD_ILS:5401132026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Nusim, Stanley.<br/>Yer Numarası RM301.25 .A28 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439803394">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Biochips as pathways to drug discoveryent://SD_ILS/0/SD_ILS:5388322026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Carmen, Andrew. Hardiman, Gary, 1966-<br/>Yer Numarası R857 .B5 B54 2007<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420015607">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Dose Optimization in Drug Developmentent://SD_ILS/0/SD_ILS:5469742026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Krishna, Rajesh, editor. Taylor and Francis.<br/>Yer Numarası RM301.8 .D67 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429136016">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Industrialization of drug discovery : from target selection through lead optimizationent://SD_ILS/0/SD_ILS:5388072026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Handen, Jeffrey S.<br/>Yer Numarası RM301.25 .I53 2005<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420028072">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>New drug development : regulatory paradigms for clinical pharmacology and biopharmaceuticsent://SD_ILS/0/SD_ILS:5423042026-01-21T20:32:23Z2026-01-21T20:32:23ZYazar Sahajwalla, Chandrahas G.<br/>Yer Numarası RA401 .A3 N48 2004<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781135533496">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>